Omar Moukha‐Chafiq

Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action

Lance A. Thielen, Junqin Chen, Jing Gu et al. · Cell Metabolism · 2020 · 106 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The G2019S mutation in LRRK2 imparts resiliency to kinase inhibition

Kaela Kelly, Shijie Wang, Ravindra Boddu et al. · Experimental Neurology · 2018 · 46 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Synthesis and biological activity of some 4-substituted 1-[1-(2,3-dihydroxy-1-propoxy)methyl-1,2,3-triazol-(4 & 5)-ylmethyl]-1H-pyrazolo[3,4-d]pyrimidines

Omar Moukha‐Chafiq, Mohamed Labd Taha, Hassan B. Lazrek et al. · Il Farmaco · 2002 · 43 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Unique Functional and Structural Properties of the LRRK2 Protein ATP-binding Pocket

Zhiyong Liu, Robert A. Galemmo, Kyle Fraser et al. · Journal of Biological Chemistry · 2014 · 32 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Studies of the Biogenic Amine Transporters 15. Identification of Novel Allosteric Dopamine Transporter Ligands with Nanomolar Potency

Richard B. Rothman, Subramaniam Ananthan, John S. Partilla et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 32 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13